Search Results - "LAU, G. K. K"

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update by Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., Dokmeci, A. K., Gane, Ed, Hou, J. L., Jafri, W., Jia, J., Kim, J. H., Lai, C. L., Lee, H. C., Lim, S. G., Liu, C. J., Locarnini, S., Al Mahtab, M., Mohamed, R., Omata, M., Park, J., Piratvisuth, T., Sharma, B. C., Sollano, J., Wang, F. S., Wei, L., Yuen, M. F., Zheng, S. S., Kao, J. H.

“…Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest rates of infection in Africa and Asia. Our understanding of the…”
Get full text

A tunable acoustic absorber using reconfigurable dielectric elastomer actuated petals by Shrestha, M., Lau, G. K., Chin, Y. W., Teo, E. H. T., Khoo, B. C., Lu, Z. B.

“…Dielectric elastomer actuator (DEA)-based unimorphs that actively bend in one direction, can mimic the blooming motion of flower petals. Here we explore an…”
Get full text

Clusterin plays an important role in hepatocellular carcinoma metastasis by LAU, S. H, SHAM, J. S. T, ZHANG, W.-M, LAU, G. K. K, YANG, M, GUAN, X.-Y, XIE, D, TZANG, C.-H, TANG, D, MA, N, HU, L, WANG, Y, WEN, J.-M, XIAO, G

“…To identify genes associated with tumor metastasis in hepatocellular carcinoma (HCC), gene expression profiles between a pair of primary HCC (H2-P) and their…”
Get full text

Efficacy of a Pre‐S Containing Vaccine in Patients Receiving Lamivudine Prophylaxis after Liver Transplantation for Chronic Hepatitis B by Lo, C.‐M., Lau, G. K., Chan, S.‐C., Fan, S.‐T., Wong, J.

“…Lamivudine monoprophylaxis against hepatitis B virus (HBV) reinfection after liver transplantation is associated with recurrence due to escape mutants and…”
Get full text

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update by Sarin, Shiv Kumar, Choudhury, Ashok, Sharma, Manoj K., Maiwall, Rakhi, Rahman, Salimur, Saigal, Sanjiv, Saraf, Neeraj, Soin, A. S., Devarbhavi, Harshad, Kim, Dong Joon, Dhiman, R. K., Taneja, Sunil, Eapen, C. E., Goel, Ashish, Ning, Q., Chen, Tao, Ma, Ke, Duan, Z., Yu, Chen, Treeprasertsuk, Sombat, Hamid, S. S., Butt, Amna S., Jafri, Wasim, Saraswat, Vivek, Sood, Ajit, Midha, Vandana, Goyal, Omesh, Ghazinyan, Hasmik, Arora, Anil, Hu, Jinhua, Sahu, Manoj, Rao, P. N., Lee, Guan H., Lim, Seng G., Lesmana, Laurentius A., Lesmana, Cosmas Rinaldi, Shah, Samir, Prasad, V. G. Mohan, Payawal, Diana A., Abbas, Zaigham, Dokmeci, A. Kadir, Sollano, Jose D., Carpio, Gian, Shresta, Ananta, Lau, G. K., Shiha, Gamal, Gani, Rino, Kalista, Kemal Fariz, Yuen, Man-Fung, Alam, Seema, Khanna, Rajeev, Sood, Vikrant, Lal, Bikrant Bihari, Pamecha, Viniyendra, Jindal, Ankur, Rajan, V., Yokosuka, Osamu, Niriella, Madunil A., Li, Hai, Tanaka, Atsushi, Chaudhuri, Dominic Ray, Gane, Ed, Win, Khin Maung, Chen, Wei Ting, Rela, Mohd, Rastogi, Amit, Kale, Pratibha, Rastogi, Archana, Bajpai, Meenu, Singh, Virender, Premkumar, Madhumita, Maharashi, Sudhir, Olithselvan, A., Srivastava, Anshu, Yachha, Surender K., Wani, Zeeshan Ahmad, Thapa, B. R., Saraya, Anoop, Shalimar, Kumar, Ashish, Gupta, Subash, Madan, Kaushal, Sakhuja, Puja, Vij, Vivek, Sharma, Barjesh C., Garg, Hitendra, Garg, Vishal, Kalal, Chetan, Anand, Lovkesh, Vyas, Tanmay, Mathur, Rajan P., Kumar, Guresh, Jain, Priyanka, Pasupuleti, Samba Siva Rao, Chawla, Yogesh K., Chowdhury, Abhijit, Alam, Shahinul, Song, Do Seon, Yang, Jin Mo, Yoon, Eileen L.

“…The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set up in 2004 on acute-on-chronic liver…”
Get full text

The associations among executive planning, self‐determination, and quality of life in adolescents with intellectual disability by Lui, M., Lau, G. K. B., Wong, P. K. S.

“…Background Skills such as planning and problem solving that are required in self‐determination can be cognitively demanding. It has not yet been examined…”
Get full text

Changes in ophthalmic artery Doppler during acute blood‐pressure control in hypertensive pregnant women by Lau, K. G., Baloi, M., Dumitrascu‐Biris, D., Nicolaides, K. H., Kametas, N. A.

“…ABSTRACT Objective To examine the changes in ophthalmic artery Doppler indices and their association with changes in mean arterial blood pressure (MAP) and…”
Get full text

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti‐viral activity of clevudine for 12 weeks in patients with chronic hepatitis B by LIM, S. G., LEUNG, N., HANN, H. W. L., LAU, G. K. K., TREPO, C., MOMMEJA‐MARIN, H., MOXHAM, C., SORBEL, J., SNOW, A., BLUM, M. R., ROUSSEAU, F., MARCELLIN, P.

“…Summary Background  Clevudine is a polymerase inhibitor that has the unusual feature of delayed viral rebound after therapy in some patients which may be…”
Get full text

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer by Lau, G K, Lok, A S, Liang, R H, Lai, C L, Chiu, E K, Lau, Y L, Lam, S K

“…Adoptive immunity transfer has been reported to be effective in clearing chronic hepatitis B virus (HBV) infection. Two hundred twenty‐six patients who…”
Get full text

Minimum graft size for successful living donor liver transplantation by LO, C.-M, FAN, S.-T, LIU, C.-L, CHAN, J. K, LAM, B. K, LAU, G. K, WEI, W. I, WONG, J

“…The extension of living donor liver transplantation to adult recipients is limited by the adequacy of the size of the graft. We evaluate the effect of the…”
Get full text

Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models by Choudhury, A., Jindal, A., Maiwall, R., Sharma, M. K., Sharma, B. C., Pamecha, V., Mahtab, M., Rahman, S., Chawla, Y. K., Taneja, S., Tan, S. S., Devarbhavi, H., Duan, Z., Yu, Chen, Ning, Q., Jia, Ji Dong, Amarapurkar, D., Eapen, C. E., Goel, A., Hamid, S. S., Butt, A. S., Jafri, W., Kim, D. J., Ghazinian, H., Lee, G. H., Sood, Ajit, Lesmana, L. A., Abbas, Z., Shiha, G., Payawal, D. A., Dokmeci, A. K., Sollano, J. D., Carpio, G., Lau, G. K., Karim, F., Rao, P. N., Moreau, R., Jain, P., Bhatia, P., Kumar, G., Sarin, S. K.

“…Background and aims Acute-on-chronic liver failure (ACLF) is a progressive disease associated with rapid clinical worsening and high mortality. Early…”
Get full text

Pharmacokinetics of pitavastatin in subjects with Child‐Pugh A and B cirrhosis by Hui, C. K., Cheung, B. M. Y., Lau, G. K. K.

“…Aim Lipid lowering therapy with 3‐hydroxy‐3‐methylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitors is increasingly used for the prevention of cardiovascular…”
Get full text

Use of functional specifications as objective functions in topological optimization of compliant mechanism by Lau, G.K., Du, H., Lim, M.K.

“…Instead of using the concepts of minimum compliance or maximum mutual compliance, alternative formulation, based on functional specification is proposed to…”
Get full text

Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B by Bonino, F, Marcellin, P, Lau, G K K, Hadziyannis, S, Jin, R, Piratvisuth, T, Germanidis, G, Yurdaydin, C, Diago, M, Gurel, S, Lai, M-Y, Brunetto, M R, Farci, P, Popescu, M, McCloud, P

“…In a trial of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B, 24 week post-treatment biochemical and virological response rates with…”
Get full text

Decline in Cancer Diagnoses during the ‘Zero COVID’ Policy in Hong Kong: Indirect Spillover Impact of the COVID-19 Pandemic by Youn, H.M., Zhang, Y., Liu, A., Ng, C.S., Liang, J., Lau, G.K.K., Lee, S.F., Lok, J., Lam, C.L.K., Wan, E.Y.F., Quan, J.

“…Despite a largely successful ‘zero COVID’ policy in 2020, the COVID-19 pandemic disrupted routine cancer services in the city of Hong Kong. The aims of this…”
Get full text

Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels by HUI, C.‐K., ZHANG, H.‐Y., SHEK, T., YAO, H., YUENG, Y.‐H., LEUNG, K.‐W., LAI, S.‐T., LAI, J.‐Y., LEUNG, N., LAU, G. K.

“…Summary Background Although chronic hepatitis C virus‐infected patients with persistently normal alanine aminotransaminase levels usually have mild liver…”
Get full text

Natural History of Patients with Recurrent Chronic Hepatitis C Virus and Occult Hepatitis B Co‐Infection after Liver Transplantation by Hui, C.‐K., Lau, E., Monto, A., Kim, M., Luk, J. M., Poon, R. T. P., Leung, N., Lo, C.‐M., Fan, S.‐T., Lau, G. K. K., Wright, T. L.

“…It is uncertain whether occult hepatitis B virus co‐infection will hasten progressive liver disease in chronic hepatitis C patients after liver…”
Get full text

48 weeks pegylated interferon alpha‐2a is superior to 24 weeks of pegylated interferon alpha‐2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection by HUI, C.‐K., LAI, L. S. W., LAM, P., ZHANG, H.‐Y., FUNG, T.‐T., LAI, S.‐T., WONG, W.‐M., LO, C.‐M., FAN, S.‐T., LEUNG, N., LAU, G. K. K.

“…Summary Background/aim  Although 48‐week therapy with pegylated‐interferons has been shown to be effective for the treatment of chronic hepatitis B virus…”
Get full text

Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation by MA, S. Y, AN, W. Y, LIE, A. K. W, NG, I. O. L, LEUNG, A. Y. H, TSE, E. W, LIANG, R. H, LAU, G. K, KWONG, Y. L

“…Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI). In 19 patients undergoing DLI for relapses of hematologic…”
Get full text

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy by Hui, C-K, Cheung, W W W, Au, W-Y, Lie, A K W, Zhang, H-Y, Yueng, Y-H, Wong, B C Y, Leung, N, Kwong, Y-L, Liang, R, Lau, G K K

“…Background: The hepatic outcome of hepatitis B surface antigen (HBsAg) positive patients undergoing chemotherapy after withdrawal of pre-emptive lamivudine is…”
Get full text